Edition:
United Kingdom

ArQule Inc (ARQL.OQ)

ARQL.OQ on NASDAQ Stock Exchange Global Market

6.21USD
25 Apr 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$6.21
Open
$6.31
Day's High
$6.36
Day's Low
$6.14
Volume
259,087
Avg. Vol
401,366
52-wk High
$7.21
52-wk Low
$2.23

About

ArQule, Inc. is a biopharmaceutical company. The Company is engaged in the research and development of therapeutics to treat cancers and rare diseases. These drugs focuses on the biological pathways implicated in a range of cancers and certain non-oncology indications. Its clinical-stage pipeline consists of over four drug... (more)

Overall

Beta: 1.20
Market Cap(Mil.): $80.42
Shares Outstanding(Mil.): 71.17
Dividend: --
Yield (%): --

Financials

  ARQL.OQ Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -0.39 -- --
ROI: -91.39 8.91 13.83
ROE: -120.33 10.06 15.25

BRIEF-Basilea Announces Collaboration To Study Derazantinib And Atezolizumab In Urothelial Cancer

* BASILEA ANNOUNCES COLLABORATION TO STUDY DERAZANTINIB AND ATEZOLIZUMAB (TECENTRIQ®) IN UROTHELIAL CANCER

24 Jan 2019

Earnings vs. Estimates